1. Home
  2. BARK vs DBVT Comparison

BARK vs DBVT Comparison

Compare BARK & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BARK
  • DBVT
  • Stock Information
  • Founded
  • BARK 2011
  • DBVT 2002
  • Country
  • BARK United States
  • DBVT France
  • Employees
  • BARK N/A
  • DBVT N/A
  • Industry
  • BARK Department/Specialty Retail Stores
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BARK Consumer Discretionary
  • DBVT Health Care
  • Exchange
  • BARK Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • BARK 244.9M
  • DBVT 289.8M
  • IPO Year
  • BARK N/A
  • DBVT N/A
  • Fundamental
  • Price
  • BARK $0.84
  • DBVT $9.00
  • Analyst Decision
  • BARK Strong Buy
  • DBVT Buy
  • Analyst Count
  • BARK 3
  • DBVT 4
  • Target Price
  • BARK $2.50
  • DBVT $14.81
  • AVG Volume (30 Days)
  • BARK 818.3K
  • DBVT 27.3K
  • Earning Date
  • BARK 08-07-2025
  • DBVT 07-29-2025
  • Dividend Yield
  • BARK N/A
  • DBVT N/A
  • EPS Growth
  • BARK N/A
  • DBVT N/A
  • EPS
  • BARK N/A
  • DBVT N/A
  • Revenue
  • BARK $484,182,000.00
  • DBVT $3,800,000.00
  • Revenue This Year
  • BARK N/A
  • DBVT $1,743.46
  • Revenue Next Year
  • BARK $9.47
  • DBVT $1,044.34
  • P/E Ratio
  • BARK N/A
  • DBVT N/A
  • Revenue Growth
  • BARK N/A
  • DBVT N/A
  • 52 Week Low
  • BARK $0.77
  • DBVT $2.21
  • 52 Week High
  • BARK $2.56
  • DBVT $12.78
  • Technical
  • Relative Strength Index (RSI)
  • BARK 38.83
  • DBVT 44.06
  • Support Level
  • BARK $0.90
  • DBVT $8.51
  • Resistance Level
  • BARK $1.01
  • DBVT $10.93
  • Average True Range (ATR)
  • BARK 0.07
  • DBVT 0.71
  • MACD
  • BARK -0.01
  • DBVT -0.15
  • Stochastic Oscillator
  • BARK 12.86
  • DBVT 20.25

About BARK BARK Inc.

BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: